Advanced search
Start date
Betweenand


IGF-I, estrogen receptor (ER) and 1 integrin interaction over PHLDA1 and PAWR transcriptional regulation

Full text
Author(s):
Débora Arcieri Casolari
Total Authors: 1
Document type: Doctoral Thesis
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Faculdade de Medicina (FM/SBD)
Defense date:
Examining board members:
Maria Aparecida Nagai; Maria Aparecida Azevedo Koike Folgueira; Durvanei Augusto Maria; Shigueko Sonohara Troyano Pueyo; Nancy Amaral Reboucas
Advisor: Maria Aparecida Nagai
Abstract

The interactions among ER, IGF-I and 1 integrin signaling pathways are essential for the maintenance of normal mammary gland homeostasis, and alterations in these pathways have been associated with mammary tumorigenesis. Therefore, the goal of this work was to investigate the influence and interaction among IGF-I, ER and 1 integrin signaling pathways on the regulation of PHLDA1 and PAWR transcription regulation. To accomplish that, MCF-7 cells were treated with 10nM 17-estradiol (E2), 12.5nM IGF-I, 30M LY294002 (a PI3-K inhibitor), 30M SB202190 (a p38MAPK inhibitor) and 1M ICI182,780 (ICI an ER antagonist), or transfected with 40nM siRNA aiming 1 integrin. Real time PCR and western blot were used to evaluate gene and protein expression, respectively. PHLDA1 mRNA expression increased after 6h of treatment with E2 (p=0.05), and this effect was inhibited by ICI (p<0.05). Treatment with E2 for 24h repressed PAWR gene expression (p<0.05) and this effect was dependent on ER, since treatment with ICI inhibited it (p<0.05). Treatment with IGF-I for 1.5h resulted in increased PHLDA1 gene expression (p<0,05) and also PHLDA1 protein expression; and treatment with IGF-I for 24h inhibited PAWR mRNA expression (p<0.05). IGF-I regulation of PAWR expression was dependent on PI3-K and p38MAPK activation. The regulation of both genes by IGF-I was independent of ER activation; however, IGF-I acted in synergism with E2 on PAWR expression resulting in lower PAWR expression than the observed after the treatments alone (p<0.05). Repression of 1 integrin expression resulted in downregulation of PHLDA1 and PAWR expression levels. No interaction was observed between IGF-I and 1 integrin on PHLDA1 and PAWR gene expression. In conclusion, PHLDA1 is positively regulated by E2 and IGF-I, but there is no interaction between them on PHLDA1 regulation. On the other hand, PAWR is negatively regulated by E2 and IGF-I; IGF-I effect is dependent on PI3-K and p38MAPK, but not on ER activation; E2 and IGF-I act synergistically on PAWR gene expression regulation (AU)